Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hand-Foot Syndrome × Celecoxib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 29 Lung Neoplasms 22 Carcinoma, Non-Small-Cell Lung 22 Breast Neoplasms 22 Colonic Neoplasms 15 Head and Neck Neoplasms 13 Rectal Neoplasms 12 Prostatic Neoplasms 10 Sarcoma 8 Neoplasm Metastasis 8 Pancreatic Neoplasms 7 Esophageal Neoplasms 7 Neoplasms 6 Mouth Neoplasms 6 Glioblastoma 6 Adenomatous Polyposis Coli 6 Precancerous Conditions 5 Ovarian Neoplasms 5 Melanoma 5 Central Nervous System Neoplasms 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Neuroblastoma 4 Gliosarcoma 4 Carcinoma 4 Urinary Bladder Neoplasms 3 Oropharyngeal Neoplasms 3 Multiple Myeloma 3

Interventions

Pyridoxine 2 tegafur-gimeracil-oteracil 1 mecobalamin 1 Vitamin B 6 1 Urea 1 Tobacco Use Cessation Devices 1 Standard of Care 1 S 1 (combination) 1 Low-Level Light Therapy 1 Diclofenac 1 Celecoxib 1 Capecitabine 1 Brimonidine Tartrate 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05327751 2022-04-14

HFS

Tanta University

Phase 3 Unknown

Gastrointestinal

Colorectal Neoplasms, Hand-Foot Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡